Omixon Founder, Attila Bérces Returns as CEO, Aims to Roll-Out New Products

We are happy to announce that Omixon’s founder and chairman Dr. Attila Bérces returns as CEO. Outgoing CEO Dr. Peter Meintjes led the early commercialization of Omixon’s flagship product Holotype HLA since 2014 before stepping into the CEO role in 2017. In concert between the incoming and outgoing CEOs,...

 

Read more

Welcome to the Team, Elmar!

We are proud to announce and welcome Elmar Schilling, who has recently joined our company as the Chief Technology Officer of Omixon. Elmar was born and raised in Bavaria, the southern part of Germany. He graduated in Molecular Biology and completed his PhD studies in the field of Epigenetics at Regensburg...

 

Read more